Lisa Blixt

Publikationer
Populärvetenskap och samverkan

Artiklar

Article: BLOOD ADVANCES. 2025;9(13):3170-3181
Outcomes of the COVID-19 pandemic in chronic lymphocytic leukemia: focus on the very early period and Omicron era
Hedberg P; Blixt L; Sylvan SE; Moller IK; Lindahl H; Kahn F; Nilsdotter-Augustinsson A; Fredrikson M; Nystrom S; Bergman P; Carlander C; Aleman S; Osterborg P; Osterborg A; Hansson L
Article: INFECTIOUS DISEASES. 2025;57(2):178-191
Risk of COVID-19 hospitalisation by HIV-status and SARS-CoV-2 vaccination status during pre- and post-Omicron era in a national register-based cohort study in Sweden
Killander Moeller I; Hedberg P; Wagner P; Lindahl H; Nystroem S; Blixt L; Eketorp Sylvan S; Nilsdotter-Augustinsson A; Oesterborg A; Fredrikson M; Hansson L; Kahn F; Sparen P; Gisslen M; Naucler P; Bergman P; Aleman S; Carlander C
Article: JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. 2025;155(2):387-397.e6
Inborn errors of immunity are associated with increased COVID-19-related hospitalization and intensive care compared to the general population
Lindahl H; Kahn F; Nilsdotter-Augustinsson A; Fredrikson M; Hedberg P; Moeller IK; Hansson L; Blixt L; Sylvan SE; Osterborg A; Aleman S; Carlander C; Nilsdotter-Augustinsson A; Nystrom S; Bergman P
Article: EJHAEM. 2025;6(1):e1077
Uptake of the first to fifth doses of coronavirus disease 2019 vaccine in individuals with chronic lymphocytic leukaemia: A nationwide cohort study in Sweden
Hedberg P; Blixt L; Granath F; Bergman P; Carlander C; Aleman S; Hansson L; CLHIP SG
Article: LEUKEMIA. 2022;36(2):476-481
Covid-19 in patients with chronic lymphocytic leukemia: clinical outcome and B- and T-cell immunity during 13 months in consecutive patients
Blixt L; Bogdanovic G; Buggert M; Gao Y; Hober S; Healy K; Johansson H; Kjellander C; Mravinacova S; Muschiol S; Nilsson P; Palma M; Pin E; Smith CIE; Stromberg O; Chen MS; Zain R; Hansson L; Osterborg A
Article: EBIOMEDICINE. 2021;74:103705
Safety and efficacy of the mRNA BNT162b2 vaccine against SARS-CoV-2 in five groups of immunocompromised patients and healthy controls in a prospective open-label clinical trial
Bergman P; Blennow O; Hansson L; Mielke S; Nowak P; Chen P; Soderdahl G; Osterborg A; Smith CIE; Wullimann D; Vesterbacka J; Lindgren G; Blixt L; Friman G; Wahren-Borgstrom E; Nordlander A; Gomez AC; Akber M; Valentini D; Norlin A-C; Thalme A; Bogdanovic G; Muschiol S; Nilsson P; Hober S; Lore K; Chen MS; Buggert M; Ljunggren H-G; Ljungman P; Aleman S

Alla övriga publikationer

Letter: HAEMATOLOGICA. 2024;109(2):646-651
Systemic and mucosal adaptive immunity to SARS-CoV-2 during the Omicron wave in patients with chronic lymphocytic leukemia
Ingelman-Sundberg HM; Blixt L; Wullimann D; Wu J; Gao Y; Healy K; Muschiol S; Bogdanovic G; Aberg M; Kjellander C; Grifoni A; Sette A; Aleman S; Chen P; Blennow O; Hansson L; Ljunggren H-G; Chen MS; Buggert M; Osterborg A
Letter: BLOOD. 2022;140(22):2403-2407
Hybrid immunity in immunocompromised patients with CLL after SARS-CoV-2 infection followed by booster mRNA vaccination
Blixt L; Gao Y; Wullimann D; Ingelman-Sundberg HM; Muschiol S; Healy K; Bogdanovic G; Pin E; Nilsson P; Kjellander C; Grifoni A; Sette A; Chen MS; Ljunggren H-G; Buggert M; Hansson L; Osterborg A
Letter: HAEMATOLOGICA. 2022;107(4):1000-1003
T-cell immune responses following vaccination with mRNA BNT162b2 against SARS-CoV-2 in patients with chronic lymphocytic leukemia: results from a prospective open-label clinical trial
Blixt L; Wullimann D; Aleman S; Lundin J; Chen P; Gao Y; Cuapio A; Akber M; Lange J; Rivera-Ballesteros O; Buggert M; Ljunggren H-G; Hansson L; Osterborg A

Artiklar

Alla övriga publikationer

Nyheter från KI

Kalenderhändelser från KI